期刊文献+

药物流产后孕妇血浆中米非司酮浓度的监测 被引量:2

Plasma Concentration Monitoring of Mifepristone in Pregnancy Women after Medical Abortion
原文传递
导出
摘要 目的:建立米非司酮血药浓度的测定方法,监测药物流产后孕妇血浆中米非司酮浓度的变化情况。方法:选择停经<49d以内,米非司酮配伍米索前列醇行药物流产的早孕妇女28例,于胎囊排出后24、48、72h时抽肘静脉血。血浆样品中米非司酮以正己烷、二氯甲烷的混合液提取后,采用HypersilODS色谱柱分离,流动相为甲醇-乙腈-水(42:28:30),流速为1.0mL.min-1,紫外检测波长为302nm。结果:米非司酮血药浓度在20~5000μg.L-1范围内线性关系良好(r=0.9983),血浆中米非司酮最低检出限为10.0μg.L-1;相对回收率在95.69%~102.25%之间;日内、日间RSD分别为2.82%~3.39%、3.19%~4.76%。28例孕妇在胎囊排出后24、48、72h时血浆中米非司酮浓度分别为(606.68±123.61)、(243.86±50.16)、(92.70±34.21)μg.L-1。结论:本方法操作简单、灵敏度高、实用性强,适合基层计划生育部门监测妊娠流产后孕妇血浆中米非司酮的浓度情况。 OBJECTIVE: To establish a method for the determination of mifepristone concentrations in plasma and monitor the changes of plasma concentrations of mifepristone in pregnancy women (Menopanse for 〈49 days) after medical abortion, METHODS: 28 cases of early pregnancy women who had terminated their pregnancy by administration of mifepristone and misoprostol were detected at the 24 h, 48 h and 72 h after discharging pregnant sac. Plasma samples were extracted with the mixture of n-hexane and dichloromethane. Chromatographic separation was conducted with a Hypersil ODS column with mobile phase consisted of methanol-acetonitrile-water (42:28:30) at a flow rate of 1.0 mL.min^-1. The UV detection wavelength was set at 302 nm. RESULTS: The linear range of mifepristone was 20-5 000 μg· L^-1 (r=0.998 3) ; the minimum detection limit was 10.0 μg· L^-1, The relative recovery was within 95.69% -102.25%. The RSDs of intra-day and inter-day were 2.82% -3.39% and 3.19% -4.76%. Mifepristone concentration of 28 cases in plasma at the 24 h, 48 h and 72 h after discharging pregnant sac were (606.68 ±123.61)μg·L ^-1, (243.86 ± 50.16)μg·L^-1 and (92.70± 34.21)μg·L^-1. CONCLUSION: The method is simple, sensitive and practical. It is suitable for the plasma concentration monitoring of mifepristone in primary family planning department.
出处 《中国药房》 CAS CSCD 2012年第6期523-525,共3页 China Pharmacy
基金 福建省公益类科研院所基本科研专项基金资助(2009R10019-2)
关键词 米非司酮 血药浓度 药物流产 高效液相色谱法 Mifepristone Plasma concentrations Medical abortion HPLC
  • 相关文献

参考文献5

二级参考文献22

  • 1邵庆翔,桑国卫,姜丽霞,桑凌,洪长福.抗孕激素米非司酮及其代谢产物的临床药代动力学[J].中国临床药理学杂志,1993,9(3):144-150. 被引量:36
  • 2焦丽娅,翁梨驹.米非司酮(RU486)的临床药理学[J].国外医学(计划生育分册),1994,13(4):230-234. 被引量:51
  • 3叶智厚,色谱,1987年,5卷,3期,179页
  • 4高善霞.米非司酮治疗更年期功血临床及病理观察[J].沂水中心医院院报,2002,171.
  • 5Bauheu. Contragestion and other chinical application of RU 486,an antiprogesterone at the receptor [J]. Science,1999, (245) : 1351.
  • 6Edward PP,Ahmann M,DeMarzo A,et ol. Progesterone receptor and mechanism of action of progesterone antiagorists[J]. J.Stemid Biochem.Molec.Biol, 1995,(53): 449.
  • 7Philibert. D,Demedt. R,Teutsch. G. A potent antiglucocorticoid in vivo,8th In Congr [J]. Pharmacol,Tokyo,Abst,1998. 1463.
  • 8Kelly. R. W,Bukman. A. Antiprogestagenic inhibition of uterine prostaglandin inactivation:a permissive mechanism for uterine atimulation.[J] J.Steroid Biochem,1997,(3):97.
  • 9Norman,J.E.Wu,W.X.Kelly. A.S and Baird,D.T.Effects of mifepristone in vivo decidual prostaglandin synthesis and metabolism[J]. Contraception, 2001, (44) : 89.
  • 10Hartsen,H.S.15-Hydroxy prostaglandin,dehydrogenase,a review[J]. Prostaglandins, 1996, (12) :647.

共引文献47

同被引文献154

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部